Tumor seroso borderline de ovarios tratamiento preservador de fertilidad: caso clínico revisión de la literatura

Castillo Guzman, Ronald; López Marcano, María victoria; López Toro, Déborah; Perfetti Girón, Wilfredo; Malaspina, María; Gimenez, María.
Rev. venez. oncol ; 31(1): 50-55, mar. 2019. ilus
Artículo en Español | LILACS, LIVECS | ID: biblio-1026536

Documentos relacionados

  1. Ovarian cancer stem cells: ready for prime time?
  2. Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary Study.
  3. A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer.
  4. Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues.
  5. Hypoxia-induced HIF1α dependent COX2 promotes ovarian cancer progress.
  6. PUM1 promotes ovarian cancer proliferation, migration and invasion.
  7. Association between atypical endometriosis and ovarian malignancies in the real world.
  8. Effects of Combined General/Epidural Anesthesia on Hemodynamics, Respiratory Function, and Stress Hormone Levels in Patients with Ovarian Neoplasm Undergoing Laparoscopy.
  9. Reproductive outcomes following fertility-sparing surgery for malignant ovarian germ cell tumors: A systematic review of the literature.
  10. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and ß-catenin-ABCG2 signaling.